These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform. Veldhuizen J; Nikkhah M J Vis Exp; 2021 Jun; (172):. PubMed ID: 34223835 [TBL] [Abstract][Full Text] [Related]
4. Toward improved myocardial maturity in an organ-on-chip platform with immature cardiac myocytes. Sheehy SP; Grosberg A; Qin P; Behm DJ; Ferrier JP; Eagleson MA; Nesmith AP; Krull D; Falls JG; Campbell PH; McCain ML; Willette RN; Hu E; Parker KK Exp Biol Med (Maywood); 2017 Nov; 242(17):1643-1656. PubMed ID: 28343439 [TBL] [Abstract][Full Text] [Related]
5. Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: Effects of niche cell supplementation and mechanical stimulation. Zhang W; Kong CW; Tong MH; Chooi WH; Huang N; Li RA; Chan BP Acta Biomater; 2017 Feb; 49():204-217. PubMed ID: 27890729 [TBL] [Abstract][Full Text] [Related]
6. Human Induced Pluripotent Stem Cell Encapsulation Geometry Impacts Three-Dimensional Developing Human Engineered Cardiac Tissue Functionality. Ellis ME; Harris BN; Hashemi M; Harvell BJ; Bush MZ; Hicks EE; Finklea FB; Wang EM; Nataraj R; Young NP; Turnbull IC; Lipke EA Tissue Eng Part A; 2022 Dec; 28(23-24):990-1000. PubMed ID: 36170590 [TBL] [Abstract][Full Text] [Related]
7. Effect of engineered anisotropy on the susceptibility of human pluripotent stem cell-derived ventricular cardiomyocytes to arrhythmias. Wang J; Chen A; Lieu DK; Karakikes I; Chen G; Keung W; Chan CW; Hajjar RJ; Costa KD; Khine M; Li RA Biomaterials; 2013 Nov; 34(35):8878-86. PubMed ID: 23942210 [TBL] [Abstract][Full Text] [Related]
11. Design and fabrication of an integrated heart-on-a-chip platform for construction of cardiac tissue from human iPSC-derived cardiomyocytes and in situ evaluation of physiological function. Zhang F; Qu KY; Zhou B; Luo Y; Zhu Z; Pan DJ; Cui C; Zhu Y; Chen ML; Huang NP Biosens Bioelectron; 2021 May; 179():113080. PubMed ID: 33639347 [TBL] [Abstract][Full Text] [Related]
12. Biowire platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Sun X; Nunes SS Methods; 2016 May; 101():21-6. PubMed ID: 26546730 [TBL] [Abstract][Full Text] [Related]
13. Metabolomics Identifies Metabolic Markers of Maturation in Human Pluripotent Stem Cell-Derived Cardiomyocytes. Bhute VJ; Bao X; Dunn KK; Knutson KR; McCurry EC; Jin G; Lee WH; Lewis S; Ikeda A; Palecek SP Theranostics; 2017; 7(7):2078-2091. PubMed ID: 28656061 [TBL] [Abstract][Full Text] [Related]
14. A highly versatile biopolymer-based platform for the maturation of human pluripotent stem cell-derived cardiomyocytes enables functional analysis in vitro and 3D printing of heart patches. Fischer B; Gwinner F; Gepp MM; Schulz A; Danz K; Dehne A; Katsen-Globa A; Neubauer JC; Gentile L; Zimmermann H J Biomed Mater Res A; 2023 Oct; 111(10):1600-1615. PubMed ID: 37317666 [TBL] [Abstract][Full Text] [Related]
15. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nunes SS; Miklas JW; Liu J; Aschar-Sobbi R; Xiao Y; Zhang B; Jiang J; Massé S; Gagliardi M; Hsieh A; Thavandiran N; Laflamme MA; Nanthakumar K; Gross GJ; Backx PH; Keller G; Radisic M Nat Methods; 2013 Aug; 10(8):781-7. PubMed ID: 23793239 [TBL] [Abstract][Full Text] [Related]
16. Cardiac ischemia on-a-chip to investigate cellular and molecular response of myocardial tissue under hypoxia. Veldhuizen J; Chavan R; Moghadas B; Park JG; Kodibagkar VD; Migrino RQ; Nikkhah M Biomaterials; 2022 Feb; 281():121336. PubMed ID: 35026670 [TBL] [Abstract][Full Text] [Related]
17. Multi-cellular interactions sustain long-term contractility of human pluripotent stem cell-derived cardiomyocytes. Burridge PW; Metzler SA; Nakayama KH; Abilez OJ; Simmons CS; Bruce MA; Matsuura Y; Kim P; Wu JC; Butte M; Huang NF; Yang PC Am J Transl Res; 2014; 6(6):724-35. PubMed ID: 25628783 [TBL] [Abstract][Full Text] [Related]
18. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications. Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518 [TBL] [Abstract][Full Text] [Related]
19. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells. Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653 [TBL] [Abstract][Full Text] [Related]
20. From engineered heart tissue to cardiac organoid. Cho J; Lee H; Rah W; Chang HJ; Yoon YS Theranostics; 2022; 12(6):2758-2772. PubMed ID: 35401829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]